OC&C supports PSG Equity’s investment in Corilus

We are pleased to congratulate PSG Equity on their investment in Corilus. OC&C provided PSG with buy-side commercial due diligence to support the deal.

Corilus is a leading medical software provider based in Belgium. The company provides the core digital patient record solution and a range of clinical & operational functionality across a range of care settings, and increasingly enables connections between various healthcare providers, patients and other stakeholders. It is used by over 30,000 care providers, including general practitioners, dentists, physiotherapists, pharmacies, and nurses. Corilus is well positioned to benefit from attractive organic and inorganic market growth opportunities in the years to come, playing its part in enabling the acceleration of the digitalisation of healthcare across Europe.

The investment fits clearly with PSG Equity’s focus on growth investments in software and tech-enabled services, and collaborative approach to supporting growth across its investments. We wish PSG and Corilus continued success.

This deal underlines OC&C’s deep expertise in vertical software and healthcare software specifically, and its continuing track record of advising on software growth strategy and transactions.

OC&C and Private Equity

We’re a leading global strategy consultancy, with vast experience across both horizontal & vertical software, working with players ranging from nascent SaaS challengers to the largest enterprise software companies. We’ve advised investors on some of the largest and most exciting transactions worldwide in recent years.

As a global strategy consulting firm, we work in close partnership with our clients to deliver outstanding results. In private equity, we have commercially advised on more than 500 successful transactions over the last 5 years, encompassing sell-side and buy-side roles.

How we can help:

• We provide commercial due diligence and vendor due diligence for transactions and refinancing.
• We assist investors with accelerating or improving their portfolio companies‘ strategy & performance
• We help investors identify potential investment themes or assets to target.